Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers

British Journal of Cancer

Volumn 84, Issue 5, 2001, Pages 659-669

  Kerkela E ^a   Ala aho, R ^b,e   Jeskanen, L ^g   Lohi, J ^f   Grenman R ^c   M Kahari V ^d,e   Saarialho Kere, U ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Departments of Dermatology and

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g NONE

Author keywords

Cytokine; Laminin 5; Stromelysin 1

Indexed keywords

CYTOKINE; GAMMA INTERFERON; KALININ; KERATINOCYTE GROWTH FACTOR; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; STROMELYSIN 2; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; METASTASIS; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SKIN FIBROBLAST; SQUAMOUS CELL CARCINOMA; WOUND HEALING;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; FIBROBLASTS; GROWTH SUBSTANCES; HUMANS; IN SITU HYBRIDIZATION; KERATOSIS; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; RNA, MESSENGER; SKIN NEOPLASMS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035793842     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1634     Document Type: Article

References (62)

1. Human collagenase-3 is expressed in malignant squamous epithelium of the skin
2. Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-γ is associated with activation of extracellular signal-regulated kinase-1,2 and STAT1
3. Lack of mda-6/WAF1/CIP1-mediated inhibition of cyclin-dependent kinases in interferon-alpha resistant murine B16 melanoma cells
4. Matrix metalloproteinases: A review
5. Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: Potential, roles in skeletal development
6. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview
7. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
8. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases
9. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family
10. Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids
11. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells
12. Membrane-type matrix metalloproteinase-1 (MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas
13. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
14. Collagenase-3 (MMP-13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor-α and transforming growth factor-β
15. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck
16. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas
17. Transformation of epithelial Madin-Darby canine kidney cells with p60(v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness
18. Matrix metalloproteinases and their inhibitors in tumour growth and invasion
19. Laminin-5 expression is independent of the injury and the microenvironment during reepithelialization of wounds
20. Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia
21. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response
22. Membrane-type matrix metalloproteinases and cell-surface-associated activation cascades for matrix metalloproteinases
23. Biochemical characterization of human collagenase-3
24. Activation of human neutrophil procollagenase by stromelysin 2
25. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme
26. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
27. Expression pattern of matrix metalloproteinases in human liver
28. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors
29. Regulation of membrane type metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate
30. Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: Implications for normal and impaired wound healing
31. The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas
32. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas
33. Analysis of MT1-MMP and MMP2 expression in human gastric cancers
34. The collagenase gene family in humans consists of at least four members
35. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours
36. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)
37. Stromelysins 1 and 2
38. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases
39. Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases
40. Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy
41. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
42. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas
43. Leukolysin/MMP25/MT6-MMP: A novel matrix metalloproteinase specifically expressed in the leukocyte lineage
44. Detection of mRNAs encoding collagenase-1 and stromelysin-2 in carcinomas of the head and neck by in situ hybridization
45. Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonar hypertension as demonstrated by in situ hybridization
46. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells
47. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas
48. Distinct localization of collagenase and TIMP expression in wound healing associated with ulcerative pyogenic granuloma
49. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing
50. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds
51. A matrix metalloproteinase expressed on the surface of invasive tumour cells
52. Cloning of the genes for human stromelysin and stromelysin 2: Differential expression in rheumatoid synovial fibroblasts
53. Laminin-5 as a marker of invasiveness in cervical lesions
54. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential
55. Mammary gland tumour formation in transgenic mice overexpressing stromelysin-1
56. Interferon-gamana coordinately upregulates matrix metalloprotease (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteases (TIMP), expression in cultured keratinocytes
57. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis
58. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations
59. Matrix-degrading proteases and angiogenesis during development and tumor formation
60. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters
61. Adhesion molecules 11: Interactions of keratinocytes with epidermal basement membrane
62. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma